These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19477356)

  • 1. Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk.
    Tang WH; Wang Z; Cho L; Brennan DM; Hazen SL
    J Am Coll Cardiol; 2009 Jun; 53(22):2061-7. PubMed ID: 19477356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
    Wang Z; Tang WH; Cho L; Brennan DM; Hazen SL
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1383-91. PubMed ID: 19542023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global arginine bioavailability ratio is decreased in patients with major depressive disorder.
    Ali-Sisto T; Tolmunen T; Viinamäki H; Mäntyselkä P; Valkonen-Korhonen M; Koivumaa-Honkanen H; Honkalampi K; Ruusunen A; Nandania J; Velagapudi V; Lehto SM
    J Affect Disord; 2018 Mar; 229():145-151. PubMed ID: 29310063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis.
    Chandrasekharan UM; Wang Z; Wu Y; Wilson Tang WH; Hazen SL; Wang S; Elaine Husni M
    Arthritis Res Ther; 2018 Jun; 20(1):123. PubMed ID: 29884228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography.
    Sourij H; Meinitzer A; Pilz S; Grammer TB; Winkelmann BR; Boehm BO; März W
    Atherosclerosis; 2011 Sep; 218(1):220-5. PubMed ID: 21632053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global arginine bioavailability, a marker of nitric oxide synthetic capacity, is decreased in PTSD and correlated with symptom severity and markers of inflammation.
    Bersani FS; Wolkowitz OM; Lindqvist D; Yehuda R; Flory J; Bierer LM; Makotine I; Abu-Amara D; Coy M; Reus VI; Epel ES; Marmar C; Mellon SH
    Brain Behav Immun; 2016 Feb; 52():153-160. PubMed ID: 26515034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifactorial risk factor intervention in patients with Type 2 diabetes improves arginine bioavailability ratios.
    Tripolt NJ; Meinitzer A; Eder M; Wascher TC; Pieber TR; Sourij H
    Diabet Med; 2012 Oct; 29(10):e365-8. PubMed ID: 22803961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Arginine/Asymmetric Dimethylarginine Ratio and Incidence of Cardiovascular Events: A Case-Cohort Study.
    Yu E; Ruiz-Canela M; Hu FB; Clish CB; Corella D; Salas-Salvadó J; Hruby A; Fitó M; Liang L; Toledo E; Ros E; Estruch R; Gómez-Gracia E; Lapetra J; Arós F; Romaguera D; Serra-Majem L; Guasch-Ferré M; Wang DD; Martínez-González MA
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1879-1888. PubMed ID: 28323949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1.
    Shao Z; Wang Z; Shrestha K; Thakur A; Borowski AG; Sweet W; Thomas JD; Moravec CS; Hazen SL; Tang WH
    J Am Coll Cardiol; 2012 Mar; 59(13):1150-8. PubMed ID: 22440215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure.
    Tang WH; Shrestha K; Wang Z; Troughton RW; Klein AL; Hazen SL
    J Card Fail; 2013 Feb; 19(2):87-93. PubMed ID: 23384633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide synthetic pathway in red blood cells is impaired in coronary artery disease.
    Eligini S; Porro B; Lualdi A; Squellerio I; Veglia F; Chiorino E; Crisci M; Garlaschè A; Giovannardi M; Werba JP; Tremoli E; Cavalca V
    PLoS One; 2013; 8(8):e66945. PubMed ID: 23940508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease.
    Lu TM; Ding YA; Charng MJ; Lin SJ
    Clin Cardiol; 2003 Oct; 26(10):458-64. PubMed ID: 14579916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal and systemic alterations of L-arginine metabolism in patients after intracerebral hemorrhage.
    Mader MM; Böger R; Appel D; Schwedhelm E; Haddad M; Mohme M; Lamszus K; Westphal M; Czorlich P; Hannemann J
    J Cereb Blood Flow Metab; 2021 Aug; 41(8):1964-1977. PubMed ID: 33461409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction.
    Nicholls SJ; Wang Z; Koeth R; Levison B; DelFraino B; Dzavik V; Griffith OW; Hathaway D; Panza JA; Nissen SE; Hochman JS; Hazen SL
    Circulation; 2007 Nov; 116(20):2315-24. PubMed ID: 17967979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The shifted balance of arginine metabolites in acute myocardial infarction patients and its clinical relevance.
    Molek P; Zmudzki P; Wlodarczyk A; Nessler J; Zalewski J
    Sci Rep; 2021 Jan; 11(1):83. PubMed ID: 33420142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric dimethylarginine predicts perioperative cardiovascular complications in patients undergoing medium-to-high risk non-cardiac surgery.
    Appel D; Böger R; Windolph J; Heinze G; Goetz AE; Hannemann J
    J Int Med Res; 2020 Aug; 48(8):300060520940450. PubMed ID: 32842812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of asymmetric dimethylarginine in plasma and aqueous humor: a key risk factor for the severity of fibrovascular proliferation in proliferative diabetic retinopathy.
    Guo X; Jin W; Xing Y
    Front Endocrinol (Lausanne); 2024; 15():1364609. PubMed ID: 38933824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease.
    Mittermayer F; Krzyzanowska K; Exner M; Mlekusch W; Amighi J; Sabeti S; Minar E; Müller M; Wolzt M; Schillinger M
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2536-40. PubMed ID: 16931791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Low Arginine/Ornithine Ratio is Associated with Long-Term Cardiovascular Mortality.
    Ishinoda Y; Masaki N; Hitomi Y; Taruoka A; Kawai A; Iwashita M; Yumita Y; Kagami K; Yasuda R; Ido Y; Toya T; Ikegami Y; Namba T; Nagatomo Y; Miyazaki K; Takase B; Adachi T
    J Atheroscler Thromb; 2023 Oct; 30(10):1364-1375. PubMed ID: 36775332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric Oxide-Related Biological Pathways in Patients with Major Depression.
    Baranyi A; Amouzadeh-Ghadikolai O; Rothenhäusler HB; Theokas S; Robier C; Baranyi M; Koppitz M; Reicht G; Hlade P; Meinitzer A
    PLoS One; 2015; 10(11):e0143397. PubMed ID: 26581044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.